Latest news with #NationalStrategyforWellbeing2031
Hi Dubai
13-06-2025
- Health
- Hi Dubai
Dubai Health Authority Approves Yas Healthcare to Build UAE's First Proton Therapy Centre
Dubai is set to become home to the UAE's first proton therapy centre, as the Dubai Health Authority (DHA) has granted initial approval to Yas Healthcare, a subsidiary of Das Holding, for the groundbreaking project. The facility, slated to begin construction in early 2026 and open by late 2028, marks a major step forward in the country's fight against cancer. The Yas Proton Therapy Centre will introduce one of the most advanced forms of cancer treatment to the region. Proton therapy delivers highly targeted radiation to tumours, significantly reducing damage to surrounding healthy tissue. This precision makes it particularly effective for paediatric cancers and tumours near vital organs. 'This centre will offer world-class, patient-focused care, reinforcing Dubai's position as a hub for advanced medical innovation,' said Dr. Alawi Alsheikh-Ali, Director-General of DHA. He highlighted the project's alignment with Dubai's long-term health strategies, including the Dubai Economic Agenda D33 and the National Strategy for Wellbeing 2031. Developed in collaboration with the National Cancer Centre Singapore (NCCS), a leader in oncology, the project will benefit from global clinical and technical expertise. NCCS will serve as the project consultant throughout the design and implementation phases. Dr. Mohamad Zaki of Yas Healthcare emphasized the growing need for such treatment, citing rising cancer rates and the advantages of proton therapy in reducing long-term side effects. Once operational, the centre will eliminate the need for regional patients to travel abroad for this specialised care, supporting Dubai's medical tourism goals and improving access to cutting-edge cancer treatment across the GCC. News Source: Emirates News Agency
Al Etihad
12-06-2025
- Health
- Al Etihad
DHA grants initial approval to Yas Healthcare to set up UAE's first proton therapy centre in Dubai
12 June 2025 18:10 DUBAI (WAM) The Dubai Health Authority (DHA) has accorded initial approval to Yas Healthcare, a subsidiary of Das Holding, to establish the UAE's first proton therapy centre in Dubai, marking a historic milestone in the advancement of cancer care in the region. The state-of-the-art facility is expected to be completed by late 2028, with construction slated to start in early will be the first dedicated centre in the UAE to offer proton therapy, a highly advanced and precise form of radiation therapy that targets tumours with exceptional accuracy while sparing healthy tissue. The treatment is especially effective for paediatric cancers and tumours located near sensitive Dubai Health Authority, Dr. Alawi Alsheikh-Ali, stated, 'Under the visionary leadership of His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister, and Ruler of Dubai, and His Highness Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum, Crown Prince of Dubai, Deputy Prime Minister, Minister of Defence, and Chairman of The Executive Council of Dubai, we are committed to positioning Dubai as a global leader in healthcare. This proton therapy centre will enhance patient care, offering world-class, patient-centred treatment and improving access to specialised care that ensures better outcomes.''This groundbreaking technology will advance cancer treatment options for our community and reinforce Dubai's goal of ranking among the top 10 cities globally for healthy life expectancy. It also strengthens Dubai's position as a key destination for advanced medical care and innovation, in line with the National Strategy for Wellbeing 2031, Dubai Social Agenda 33, and the Dubai Economic Agenda D33.'Proton therapy is a highly precise and advanced radiation treatment that delivers targeted doses to cancerous tumours while sparing surrounding healthy tissue. This minimises side effects and is particularly effective for treating paediatric cancers and complex or sensitive tumour sites. The Yas Proton Therapy Centre will provide patients across the region with access to this specialised treatment for the first time, eliminating the need to travel abroad for project will be developed in strategic collaboration with the National Cancer Centre Singapore (NCCS), one of Asia's leading authorities in oncology. NCCS will serve as the project consultant, bringing global clinical and technical expertise to the design and implementation of the Director and General Manager of Yas Healthcare, Dr. Mohamad Zaki, said, 'Global data indicates a rising number of cancer diagnoses, particularly among younger patients. Proton therapy provides a treatment option with fewer side effects and lower toxicity for certain cancer types. The Yas Proton Therapy Centre aims to improve accessibility and reduce costs by offering this treatment closer to home.'Chair of the Division of Radiation Oncology at the National Cancer Centre Singapore, Dr. Michael Wang, added, 'This milestone collaboration with Yas Healthcare reflects the National Cancer Centre Singapore's leadership in radiation oncology, operating one of the largest proton beam facilities in Southeast Asia. We are excited to contribute our expertise as Yas Healthcare introduces this advanced technology to redefine cancer treatment in the GCC.'The move to develop the new facility directly aligns with the National Strategy for Wellbeing 2031, the Dubai Social Agenda 33, and the Dubai Economic Agenda D33 — key initiatives to enhance quality of life, improve health outcomes, and position Dubai as a premier destination for medical innovation and tourism. Dubai's Medical Tourism Vision also aims to attract more than 500,000 international patients annually by work related to the project is scheduled to begin in early 2026 and the facility is expected to be operational by the end of 2028. Yas Healthcare's official platforms will provide updates on the progress of the project and patient enrolment programmes.
Gulf Today
22-05-2025
- Health
- Gulf Today
FOCP, EHS to drive cancer detection efforts
Friends of Cancer Patients (FOCP) and Emirates Health Services (EHS) have signed a new partnership at Sofitel Dubai The Obelisk, to enhance cooperation in cancer prevention, early detection, and to provide both moral and financial support to patients across the UAE. The agreement, signed by Dr Shamsa Majid Lootah, Director of the Public Health Department at EHS, and Aisha Al Mulla, Director of FOCP, underscores FOCP's ongoing commitment to working collaboratively with national healthcare institutions to benefit the wider community. It sets out a framework for expanding early detection programmes and strengthening both financial and emotional assistance for patients. EHS has long been a strategic partner of FOCP, with both organisations having previously joined forces on cancer awareness initiatives. The renewed partnership provides a platform to broaden the scope of collaboration and align efforts in support of the UAE's national strategy to curb cancer prevalence and lessen its impact on patients and their families. Commenting on the partnership, Dr. Essam Al Zarouni, Acting Executive Director of the Medical Services Sector at EHS, affirmed that the MoU represents an advanced integration model among national sectors pursuing the country's healthcare goals. This collaboration aligns with the National Strategy for Wellbeing 2031 objectives and the UAE Centennial 2071. For her part, Dr Shamsa Lootah highlighted that EHS is committed to expanding strategic partnerships with key community stakeholders to support its focus on disease prevention and early detection, particularly for cancer. Through ongoing awareness programmes and initiatives, EHS aims to raise public awareness, encourage healthy lifestyles and improve early diagnosis and treatment, in line with its commitment to comprehensive healthcare. Aisha Al Mulla, Director of FOCP, said: 'The new partnership with EHS represents a significant step forward in our shared mission to raise community awareness of cancer and strengthen patient support systems. It builds on a longstanding collaboration between us.
Sharjah 24
21-05-2025
- Health
- Sharjah 24
FOCP, EHS partner to drive national cancer detection efforts
The agreement, signed by Dr Shamsa Majid Lootah, Director of the Public Health Department at EHS, and Aisha Al Mulla, Director of FOCP, underscores FOCP's ongoing commitment to working collaboratively with national healthcare institutions to benefit the wider community. It sets out a framework for expanding early detection programmes and strengthening both financial and emotional assistance for patients. EHS has long been a strategic partner of FOCP, with both organisations having previously joined forces on cancer awareness initiatives. The renewed partnership provides a platform to broaden the scope of collaboration and align efforts in support of the UAE's national strategy to curb cancer prevalence and lessen its impact on patients and their families. A strategic step towards shared goals Commenting on the partnership, Dr. Essam Al Zarouni, Acting Executive Director of the Medical Services Sector at EHS, affirmed that the MoU represents an advanced integration model among national sectors pursuing the country's healthcare goals. This collaboration aligns with the National Strategy for Wellbeing 2031 objectives and the UAE Centennial 2071. For her part, Dr. Shamsa Lootah highlighted that EHS is committed to expanding strategic partnerships with key community stakeholders to support its focus on disease prevention and early detection, particularly for cancer. Through ongoing awareness programmes and initiatives, EHS aims to raise public awareness, encourage healthy lifestyles and improve early diagnosis and treatment, in line with its commitment to comprehensive healthcare. Aisha Al Mulla, Director of FOCP, said: 'The new partnership with EHS represents a significant step forward in our shared mission to raise community awareness of cancer and strengthen patient support systems. It builds on a longstanding collaboration between us. It reflects our joint conviction that coordinated efforts between the non-profit and healthcare sectors are vital to advancing early detection, improving prevention, and alleviating the challenges faced by patients and their families throughout their treatment journey.' Patient support and assessment As part of the agreement, FOCP's Patient Affairs Department will assess each cancer case to determine eligibility for financial assistance, in line with the organisation's established policies and procedures. In parallel, it will provide moral support, acknowledging its essential role in enhancing treatment outcomes and overall patient well-being. Awareness campaigns and joint programmes FOCP and EHS will collaborate on early cancer detection initiatives through public awareness campaigns, joint research projects, and specialised workshops and conferences. These efforts are designed to expand access to cancer-related services within the community, supporting prevention, early detection, and effective treatment.
Campaign ME
08-05-2025
- Business
- Campaign ME
The brand strategy behind DAMAC's Chelsea Residences
DAMAC Properties has revealed its Chelsea Residences by DAMAC, its residential development born from its global partnership with Chelsea FC. The branded homes aim to blend Chelsea's heritage with DAMAC's luxury credentials. Campaign Middle East spoke with Amira Sajwani, Managing Director of Sales & Development of DAMAC Properties and Todd Kline, President – Commercial, Chelsea Football Club to uncover the 'why' behind the branded residence. 'To be at the forefront of branded residences, bringing different brand identities into our projects is something we're very passionate about,' Sajwani said. To explore this interest, she stated the next arena that the group wanted to explore was health and longevity. 'This is a goal that aligns with the UAE's vision over the next 10 years as well,' she said, in reference to the UAE's National Strategy for Wellbeing 2031. Further building on this, Kline spoke to Chelsea's incentive behind the partnership. 'While Chelsea is a football club at heart, we really are a lifestyle brand,' he said. 'This project is a great brand extension to actually have our fans and football fans in general to be immersed in all things Chelsea.' Kline stated that DAMAC was an obvious choice to partner with to bring the Chelsea brand to the world. 'There's a very small percentage of our fan base that will actually get a chance to come to Stamford Bridge, or meet a player,' he said. 'A brand such as DAMAC is synonymous with luxury, design and craftsmanship and that's something that speaks right to the heart of what Chelsea FC is all about,' he said. 'To push the envelope and do things that have never been done before.' Both brand ambassadors said that creating an immersive experience into the Chelsea FC brand is another factor behind the Chelsea Residences. Sajwani listed several tailored amenities that the property will offer to consumers in the region. This includes a rooftop Chelsea FC branded football pitch, a fitness club that will offer the same treatments as Chelsea FC footballers and more. 'Consumers can expect the project to be as quirky as having the building light up every time Chelsea scores a goal,' Sajwani said. Looking ahead, DAMAC and Chelsea FC plan to bring more experiences to audiences in the region and the UK over the three-year agreement leveraging the Stamford Stadium, social media campaigns, and digital experiences.
